|
DNMT3B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.98559999962245E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.259600E-03 |
| Normal-vs-Stage2 |
5.791800E-02 |
| Normal-vs-Stage3 |
1.66617999999286E-05 |
| Normal-vs-Stage4 |
3.51080000005055E-06 |
| Stage1-vs-Stage2 |
7.153000E-01 |
| Stage1-vs-Stage3 |
3.819800E-03 |
| Stage1-vs-Stage4 |
1.040640E-03 |
| Stage2-vs-Stage3 |
5.656000E-03 |
| Stage2-vs-Stage4 |
1.396610E-03 |
| Stage3-vs-Stage4 |
4.573200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.24229999976767E-07 |
| Normal-vs-AfricanAmerican |
3.190500E-02 |
| Normal-vs-Asian |
1.759960E-01 |
| Caucasian-vs-AfricanAmerican |
4.901800E-01 |
| Caucasian-vs-Asian |
3.462600E-01 |
| AfricanAmerican-vs-Asian |
2.542400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.34849999999343E-05 |
| Normal-vs-Female |
1.62765999999204E-05 |
| Male-vs-Female |
2.869600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.355700E-02 |
| Normal-vs-Age(41-60Yrs) |
4.03159999999847E-05 |
| Normal-vs-Age(61-80Yrs) |
2.09129999999558E-05 |
| Normal-vs-Age(81-100Yrs) |
1.328230E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.605600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.501600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.371800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.489400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.615000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.742200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.915800E-03 |
| Normal-vs-Grade 2 |
2.558500E-03 |
| Normal-vs-Grade 3 |
1.69837999999256E-05 |
| Normal-vs-Grade 4 |
2.32199999999905E-05 |
| Grade 1-vs-Grade 2 |
2.437000E-01 |
| Grade 1-vs-Grade 3 |
7.522600E-01 |
| Grade 1-vs-Grade 4 |
1.973990E-01 |
| Grade 2-vs-Grade 3 |
3.648400E-02 |
| Grade 2-vs-Grade 4 |
2.858200E-03 |
| Grade 3-vs-Grade 4 |
5.932400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.175000E-03 |
| Normal-vs-ccB subtype |
2.31769999999853E-05 |
| ccA subtype-vs-ccB subtype |
8.758500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.21299999999736E-05 |
| Normal-vs-N1 |
9.479200E-03 |
| N0-vs-N1 |
2.060300E-02 |
|
|
